Skip to content
Home/Companies/Biotech/CureVac
CU

CureVac

Biotech·Germany·Exited 2025·Held 20yr

CureVac is a biotech company, headquartered in Germany.

Entry
2005
Hold
20yr
Exit
2025
Est. EV
–

Who owns CureVac?

CureVac was owned by dievini Hopp BioTech holding through dievini Hopp BioTech holding (Evergreen Balance Sheet) (2005 vintage) from 2005 to 2025, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-03

dievini Hopp BioTech holding
Investor
dievini Hopp BioTech holding
dievini Hopp BioTech holding (Evergreen Balance Sheet) · 2005 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2025

More from dievini Hopp BioTech holding (Evergreen Balance Sheet)

Other portfolio companies in the same fund.

Heidelberg Pharma
Active
BiotechGermany· 2009
Novaliq
Active
PharmaGermany· 2007
Immatics
Active
BiotechGermany· 2006
Apogenix
Active
BiotechGermany· 2005
Molecular Health
Active
SaaSGermany· 2004

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings